No Data
Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.
Express News | Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services
Scinai Immunotherapeutics Announces The Establishment Of A U.S.-Based Subsidiary For Its Contract Development And Manufacturing Services
Press Release: Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board
Scinai Immunotherapeutics' (NASDAQ:SCNI) Earnings Might Be Weaker Than You Think
Scinai Immunotherapeutics Reports Financial Turnaround and Growth
No Data
